Bilirakis-Type Elderly Drug Benefit Could Take Three Years - Reishauer
Expanding state pharmaceutical assistance programs in order to offer drug coverage to more seniors could take two or three years, The Brookings Institution Senior Fellow Robert Reishauer testified before the House Commerce/Health and Environment Subcommittee Sept. 28.
You may also be interested in...
The New York Senate race will offer a sharp contrast in approaches to making pharmaceuticals more affordable to the elderly.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011